Skip to content

Xpede Clinical Study

A Prospective, 1: 1 Randomized, Single Blind, Multi-center Human Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03730207
Enrollment
180
Registered
2018-11-05
Start date
2018-12-18
Completion date
2021-10-14
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathological Fracture of Vertebra Due to Neoplastic Disease (Disorder), Pathological Fracture of Vertebra Due to Secondary Osteoporosis (Disorder)

Brief summary

The purpose of this clinical study is to confirm the efficacy and safety of the Kyphon®Xpede™ Bone Cement in human use in China.

Interventions

DEVICEXpede™ Bone Cement

Xpede™ Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.

DEVICEMendec Spine Bone Cement

Mendec Spine Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.

Sponsors

Medtronic Spinal and Biologics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subject being diagnosed as having painful pathological vertebral body fracture, who is suitable for VP/BKP procedure (1-3 levels) according to clinic practice. 2. Subjects who are willing to participate in study through consent and willing to undergo study specific required procedures with expectancy of geographically stable for follow up duration. 3. Subjects are at least 18 and ≤80 years old .

Exclusion criteria

1. Subject has a local or systemic infection. 2. Subject has pains caused by other spine disease than painful pathological vertebral compression fracture. 3. Subject has a medical condition with less than 1 year of life expectancy. 4. Subject is grossly obese, i.e. BMI≥40. 5. Subject has medical conditions that represent contraindications for the use of bone cement by investigator's decision. 6. Subject has an allergy or an intolerance to bone cement component. 7. Subject has past spinal surgeries at the target level(s) for which the VP/BKP procedure is suitable. 8. Subjects who are currently enrolled or planning to participate in a potentially confounding drug or device trial during the course of this study. Co-enrollment in concurrent trials is only allowed when document pre-approval is obtained from the Medtronic study manager and Medtronic Medical Advisor. 9. Pregnant women or breastfeeding women, or women of child bearing potential who are not on a reliable form of birth regulation method or abstinence. 10. Subjects with

Design outcomes

Primary

MeasureTime frameDescription
The Change of Numerical Rating Scale (NRS) Score From Baseline at 6 Months PostoperativeBaseline and 6 monthsNRS is used for rating patient pain intensity from 0-10, with a score of 0 representing no pain and a score of 10 representing pain as bad as it could be.
The Change of Index Vertebral Body Angle From Baseline at 6 MonthsBaseline and 6 monthsVertebral body angle is defined the angle formed by lines drawn parallel to the superior endplate of the fractured vertebral body and the inferior endplate of the fractured vertebral body for each fractured vertebral body.

Secondary

MeasureTime frameDescription
The Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsBaseline, 1 day, 3 months, and 6 monthsThe Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) is used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS/MCS is between 0 and 100, with higher scores denoting better quality of life.
Change in Vertebral Body Height at 1 Day, 3 Months, and 6 Months1 day, 3 months, and 6 monthsVertebral Body Height in the lateral projection will be measured at each treated vertebra as well as the next adjacent vertebrae (superior and inferior) without fracture and reported in millimeters. Vertebral Body Height is the distance between comparable points on the superior and inferior endplates of the vertebral body at the posterior (Hp), midline (Hm) and anterior (Ha) locations。
The Change of NRS Score From Baseline at 1 Day and 3 MonthsBaseline, 1 day, and 3 monthsNRS is used for rating patient pain intensity from 0-10, with a score of 0 representing no pain and a score of 10 representing pain as bad as it could be.
Number of Participants With Adverse Events Reported Through 6 Months6 monthsAdverse events reported through 6 months, in particular, the following events will be reported: * Bone Cement Implantation Syndrome; * Bone Cement leakage; * Vertebral body compression fracture; * Adjacent vertebral body fracture;
Change in Vertebral Body Angle From Baseline at 1 Day and 3 MonthsBaseline, 1 day and 3 monthsVertebral body angle is defined the angle formed by lines drawn parallel to the superior endplate of the fractured vertebral body and the inferior endplate of the fractured vertebral body for each fractured vertebral body.
The Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsBaseline, 1 day, 3 months, and 6 monthsODI Questionnaire is used to assess patient back function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).

Countries

China

Participant flow

Participants by arm

ArmCount
Xpede™ Bone Cement
The subjects in this group will be injected the Xpede™ Bone Cement into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body. Xpede™ Bone Cement: Xpede™ Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.
89
Mendec Spine Bone Cement
The subjects in this group will be injected the Mendec Spine Bone Cement into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body. Mendec Spine Bone Cement: Mendec Spine Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.
91
Total180

Baseline characteristics

CharacteristicXpede™ Bone CementTotalMendec Spine Bone Cement
Age, Continuous68.1 years
STANDARD_DEVIATION 5.59
67.6 years
STANDARD_DEVIATION 6.38
67.1 years
STANDARD_DEVIATION 7.06
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
89 Participants180 Participants91 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
China
89 participants180 participants91 participants
Sex: Female, Male
Female
74 Participants148 Participants74 Participants
Sex: Female, Male
Male
15 Participants32 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 891 / 91
other
Total, other adverse events
12 / 897 / 91
serious
Total, serious adverse events
1 / 891 / 91

Outcome results

Primary

The Change of Index Vertebral Body Angle From Baseline at 6 Months

Vertebral body angle is defined the angle formed by lines drawn parallel to the superior endplate of the fractured vertebral body and the inferior endplate of the fractured vertebral body for each fractured vertebral body.

Time frame: Baseline and 6 months

ArmMeasureValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementThe Change of Index Vertebral Body Angle From Baseline at 6 Months-0.869 degree
Mendec Spine Bone CementThe Change of Index Vertebral Body Angle From Baseline at 6 Months-0.952 degree
Primary

The Change of Numerical Rating Scale (NRS) Score From Baseline at 6 Months Postoperative

NRS is used for rating patient pain intensity from 0-10, with a score of 0 representing no pain and a score of 10 representing pain as bad as it could be.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
Xpede™ Bone CementThe Change of Numerical Rating Scale (NRS) Score From Baseline at 6 Months Postoperative-4.2 scoreStandard Deviation 2.86
Mendec Spine Bone CementThe Change of Numerical Rating Scale (NRS) Score From Baseline at 6 Months Postoperative-4.4 scoreStandard Deviation 2.76
Secondary

Change in Vertebral Body Angle From Baseline at 1 Day and 3 Months

Vertebral body angle is defined the angle formed by lines drawn parallel to the superior endplate of the fractured vertebral body and the inferior endplate of the fractured vertebral body for each fractured vertebral body.

Time frame: Baseline, 1 day and 3 months

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementChange in Vertebral Body Angle From Baseline at 1 Day and 3 MonthsChange in Vertebral body angle from baseline at 3 months-1.710 degree
Xpede™ Bone CementChange in Vertebral Body Angle From Baseline at 1 Day and 3 MonthsChange in Vertebral body angle from baseline at 1 day-2.739 degree
Mendec Spine Bone CementChange in Vertebral Body Angle From Baseline at 1 Day and 3 MonthsChange in Vertebral body angle from baseline at 3 months-1.662 degree
Mendec Spine Bone CementChange in Vertebral Body Angle From Baseline at 1 Day and 3 MonthsChange in Vertebral body angle from baseline at 1 day-2.375 degree
Secondary

Change in Vertebral Body Height at 1 Day, 3 Months, and 6 Months

Vertebral Body Height in the lateral projection will be measured at each treated vertebra as well as the next adjacent vertebrae (superior and inferior) without fracture and reported in millimeters. Vertebral Body Height is the distance between comparable points on the superior and inferior endplates of the vertebral body at the posterior (Hp), midline (Hm) and anterior (Ha) locations。

Time frame: 1 day, 3 months, and 6 months

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 3 months-3.949 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 6 months-3.426 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 1 day-2.375 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 1 day-0.128 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 1 day-2.514 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 3 months-0.821 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 3 months-3.727 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 6 months-0.862 millimetre
Xpede™ Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 6 months-4.271 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 6 months-1.451 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 6 months-4.429 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 3 months-4.154 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Anterior height) restoration at 1 day-2.738 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 1 day-2.845 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 3 months-3.979 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Mid-vertebral height) restoration at 6 months-3.603 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 1 day-0.613 millimetre
Mendec Spine Bone CementChange in Vertebral Body Height at 1 Day, 3 Months, and 6 MonthsChange in vertebral body height (Posterior height) restoration at 3 months-1.579 millimetre
Secondary

Number of Participants With Adverse Events Reported Through 6 Months

Adverse events reported through 6 months, in particular, the following events will be reported: * Bone Cement Implantation Syndrome; * Bone Cement leakage; * Vertebral body compression fracture; * Adjacent vertebral body fracture;

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Xpede™ Bone CementNumber of Participants With Adverse Events Reported Through 6 Months28 Participants
Mendec Spine Bone CementNumber of Participants With Adverse Events Reported Through 6 Months32 Participants
Secondary

The Change of NRS Score From Baseline at 1 Day and 3 Months

NRS is used for rating patient pain intensity from 0-10, with a score of 0 representing no pain and a score of 10 representing pain as bad as it could be.

Time frame: Baseline, 1 day, and 3 months

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementThe Change of NRS Score From Baseline at 1 Day and 3 MonthsThe change of NRS score from baseline at 1 day-2.9 score
Xpede™ Bone CementThe Change of NRS Score From Baseline at 1 Day and 3 MonthsThe change of NRS score from baseline at 3 months-3.6 score
Mendec Spine Bone CementThe Change of NRS Score From Baseline at 1 Day and 3 MonthsThe change of NRS score from baseline at 1 day-2.3 score
Mendec Spine Bone CementThe Change of NRS Score From Baseline at 1 Day and 3 MonthsThe change of NRS score from baseline at 3 months-3.8 score
Secondary

The Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 Months

ODI Questionnaire is used to assess patient back function. The ODI score ranges from 0-100. The best score is 0 (no disability) and worst is 100 (maximum disability).

Time frame: Baseline, 1 day, 3 months, and 6 months

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 3 months-26.407 score on a scale
Xpede™ Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 6 months-26.407 score on a scale
Xpede™ Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 1 day-1.757 score on a scale
Mendec Spine Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 3 months-29.108 score on a scale
Mendec Spine Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 6 months-29.108 score on a scale
Mendec Spine Bone CementThe Change of Oswestry Disability Index (ODI) Score From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of ODI score from baseline 1 day1.746 score on a scale
Secondary

The Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 Months

The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) is used to assess general health status. The SF-36 results were summarized into two components, a physical component summary (PCS) and a mental component summary (MCS). The score for PCS/MCS is between 0 and 100, with higher scores denoting better quality of life.

Time frame: Baseline, 1 day, 3 months, and 6 months

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS)from baseline at 6 months3.781 score on a scale
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS) from baseline at 3 months5.740 score on a scale
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS)from baseline at 1 day0.650 score on a scale
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 6 months7.855 score on a scale
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 3 months5.740 score on a scale
Xpede™ Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 1 day-3.104 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 3 months6.504 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS)from baseline at 6 months-1.436 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 6 months9.683 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS) from baseline at 3 months0.086 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(PCS)from baseline at 1 day-3.654 score on a scale
Mendec Spine Bone CementThe Change of SF-36 From Baseline at 1 Day, 3 Months, and 6 MonthsThe change of SF-36(MCS)from baseline at 1 day0.809 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026